Life Sciences Capital Forum | Executive Webinar
Operational Readiness
Across Capital Programs
Readiness starts long before handover.
What does it take to move a life sciences facility from project plans to operational reality?
Join us for a roundtable discussion hosted by Joanne Meloro, featuring four industry leaders
exploring the people, infrastructure, and decisions that shape readiness, well before startup.
Date: Tuesday, November 10, 2026
Time: 12:00 PM - 1:00 PM ET
Format note: Scheduled virtual executive roundtable.
Register to receive your webinar access link and reminders.
Five perspectives. One shared challenge.
A conversation spanning facility execution, quality, workforce, municipal readiness, and leadership.
ROUNDTABLE HOST
Joanne Meloro
Life sciences capital execution, CQV, and operational readiness.
Dwayne Ariola
Featured Guest
Life sciences business development, CQV, and coordination across industry and communities.
Scott Willis
Featured Guest
Economic development, municipal infrastructure, and life sciences workforce planning.
Mark O’Donnell
Featured Guest
Leadership systems, organizational alignment, and manufacturing facility execution.
Tommy O’Donnell
Featured Guest
Partner & Life Sciences Advisor, Quality, validation, environmental monitoring, and facility turnover.
Who this roundtable is for
Designed for experienced professionals actively involved in capital execution in life sciences - those who own outcomes, not just inputs.
- Capital project leaders overseeing portfolios of life sciences facility expansion and modernization
- Engineering and facilities leaders accountable for scope, schedule, and technical risk
- Validation and CQV leaders managing multi-site, multi-vendor validation programs
- Manufacturing leadership preparing to receive and operate new assets and lines
- Operations executives responsible for start-up readiness and regulatory inspection outcomes
If you are adjacent to capital execution but not directly responsible for outcomes, this session is unlikely to be the right fit.
The Life Sciences Capital Forum
The Life Sciences Capital Forum is an executive roundtable series focused on capital execution across modern GMP programs.
ROUNDTABLES THAT MATTER
- Closed‑door, moderated executive roundtables
- Focused on capital execution, CQV, and operational readiness
- Built for leaders accountable for schedule, quality, and compliance
- Structured as an ongoing series, not one‑off broadcasts
What this session covers
Grounded in active life sciences capital projects — not theory — this roundtable distills what operators are actually seeing across their portfolios.
Where projects lose momentum
Real examples of where life sciences capital projects fall behind: scope creep, decision latency, and late‑surfacing CQV issues that erode float and push operational readiness to the edge.
Workforce & validation constraints
How CQV and validation resource shortages are reshaping capital execution life sciences strategies — and what leaders are doing to avoid late‑stage validation risk on critical assets.
Coordination & lessons learned
Multi‑vendor coordination across EPC, OEMs, integrators, and CQV teams — where it breaks, how leaders are tightening interfaces, and the specific practices they are carrying forward into the next wave of pharma capital projects.
Format: peer discussion, not presentations
- Moderated, conversational roundtable with senior leaders
- No slides, no marketing decks, no scripted demos
- No selling - this is not a vendor webinar
- Recorded to create thought leadership for the Life Sciences Capital Forum
- Focus on practical patterns, decision frameworks, and lessons learned
You should expect a candid, off‑PowerPoint discussion framed by a light moderation - not a broadcast to a broad, anonymous audience.
Executive conversations on capital execution, operational readiness, and the relationships that help life sciences programs succeed.